Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMITRIPTYLINE vs DOXEPIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMITRIPTYLINE vs DOXEPIN: Safety Overview

Metric AMITRIPTYLINE DOXEPIN
Total FAERS Reports 20,382 4,021
Deaths Reported 4,837 1,613
Death Rate 23.7% 40.1%
Hospitalizations 7,290 1,091
Average Patient Age 55.2 yrs 49.2 yrs
% Female Patients 70.9% 63.8%
FDA Approval Date Approved Prior to Jan 1, 1982 Approved Prior to Jan 1, 1982
Manufacturer Proficient Rx LP Teva Pharmaceuticals USA, Inc.
Route ORAL TOPICAL
Marketing Status Discontinued Discontinued